Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Novartis
Fish and Richardson
Citi
Boehringer Ingelheim
Baxter
Cerilliant
McKinsey
Harvard Business School
Queensland Health

Generated: February 22, 2018

DrugPatentWatch Database Preview

Us Worldmeds Company Profile

« Back to Dashboard

Summary for Us Worldmeds
International Patents:76
US Patents:3
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Us Worldmeds

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds REVONTO dantrolene sodium INJECTABLE;INJECTION 078378-001 Jul 24, 2007 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes 8,283,380 ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes 8,278,485 ➤ Try a Free Trial Y ➤ Try a Free Trial
Us Worldmeds Llc XADAGO safinamide mesylate TABLET;ORAL 207145-002 Mar 21, 2017 RX Yes Yes 8,076,515 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-001 Jul 24, 2002 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Us Worldmeds

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 3,935,267 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-004 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 3,982,021 ➤ Try a Free Trial
Us Worldmeds Llc ZELNORM tegaserod maleate TABLET;ORAL 021200-002 Jul 24, 2002 5,510,353 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Us Worldmeds

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,901,176 Methods for treatment of Parkinson's disease ➤ Try a Free Trial
9,492,410 Methods for treatment of Parkinson's disease ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Us Worldmeds Drugs

Supplementary Protection Certificates for Us Worldmeds Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0752 Netherlands ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
0505322/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: TEGASEROD; REGISTRATION NO/DATE:IKS 55689 20011030
C0054 France ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
/2015 Austria ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
2015 00042 Denmark ➤ Try a Free Trial PRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
2015 00042 Denmark ➤ Try a Free Trial PRODUCT NAME: KOMBINATION AF SAFINAMID OG LEVOPODA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150224
1 50017-2015 Slovakia ➤ Try a Free Trial PRODUCT NAME: SAFINAMID; REGISTRATION NO/DATE: EU/1/14/984/001 - EU/1/14/984/010 20150226
782 Luxembourg ➤ Try a Free Trial PRODUCT NAME: SAFINAMIDE A UTILISER EN COMBINAISON AVEC LEVODOPA/PDI, ET EVENTUELLEMENT AVEC D'AUTRES MEDICAMENTS PD , POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON; FIRST REGISTRATION DATE: 20150224
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Medtronic
Cerilliant
Colorcon
Mallinckrodt
McKesson
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot